Sub Banner Image

65 Equity Makes Europe Foray With Swiss Pharma Merger

Markets

Swetha Gopinath

·

March 30, 2025

·

Bloomberg

Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s acquisition of Cerbios-Pharma SA, marking its first deal in Europe.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.